Historical salary details - Dr. Charles M. Baum, M.D.,PhD, Independent Director, Poseida Therapeutics Inc
Dr. Charles M. Baum, M.D.,PhD is the Independent Director of Poseida Therapeutics Inc.
Dr. Charles M. Baum, M.D.,Phd
Independent Director
-
Gross Remuneration
-
Current Company
Poseida Therapeutics Inc
| YEAR | COMPANY | POSITION | SALARY | INCREMENT |
|---|---|---|---|---|
| 2025 | Poseida Therapeutics Inc | Independent Director | - | - |
| 2024 | PMV Pharmaceuticals Inc | Independent Director | - | - |
| 2024 | Acrivon Therapeutics Inc | Independent Director | - | - |
| 2023 | Acrivon Therapeutics Inc | Independent Director | 325.1 K | - |
| 2023 | Poseida Therapeutics Inc | Independent Director | 150.3 K | -22.9 % |
| 2023 | PMV Pharmaceuticals Inc | Independent Director | 133.3 K | -41.6 % |
| 2023 | Mirati Therapeutics Inc | Director and Interim Chief Executive Officer | - | - |
| 2022 | PMV Pharmaceuticals Inc | Independent Director | 228.1 K | -79.3 % |
| 2022 | Poseida Therapeutics Inc | Independent Director | 194.9 K | - |
| 2022 | Mirati Therapeutics Inc | President, Head of Research and Development and Di | - | - |
| 2021 | PMV Pharmaceuticals Inc | Independent Director | 1.1 M | - |
| 2020 | PMV Pharmaceuticals Inc | Independent Director | - | - |